Valuation: aXichem AB

Market Cap 135M 13.48M 11.97M 11.2M 10.2M 19.21M 1.3B 19.47M 52.44M 661M 50.61M 49.51M 2.12B P/E 2024
-2.93x
P/E 2025 -6.9x
Enterprise Value 137M 13.64M 12.12M 11.33M 10.33M 19.44M 1.31B 19.71M 53.07M 669M 51.23M 50.12M 2.15B EV / Sales 2024
7.67x
EV / Sales 2025 6.72x
Free-Float
82.56%
Yield 2024 *
-
Yield 2025 -
1 day-4.75%
1 week-9.29%
Current month-11.40%
1 month-12.61%
3 months-10.98%
6 months+31.38%
Current year-7.97%
1 week 1.86
Extreme 1.86
2.25
1 month 1.7
Extreme 1.7
2.31
Current year 1.14
Extreme 1.135
4
1 year 1.14
Extreme 1.135
4
3 years 0.9
Extreme 0.898
15.5
5 years 0.9
Extreme 0.898
30.8
10 years 0.9
Extreme 0.898
95.8
Manager TitleAgeSince
Chief Executive Officer 69 2015-12-31
Chief Operating Officer 51 2025-04-15
Investor Relations Contact 64 2014-12-31
Director TitleAgeSince
Chairman 69 2007-07-05
Chairman 80 2016-12-31
Director/Board Member 77 2016-12-31
Date Insider Type Main position Quantity % Market Cap. Importance
3/28/24 Exercice

Director

134,408 0.6253%
3/28/24 Exercice

Director

33,602 0.1563%
3/27/24 Buy

Founder

200,000 0.9304%
Change 5-day change 1-year change 3-year change Capi.($)
-4.75%-9.29%-38.35%-77.95% 13.48M
-1.21%-1.49%+0.57%+60.13% 76.04B
+0.13%-2.67%+3.68%+14.12% 37.12B
+1.65%-0.52%+2.16%-20.80% 34.6B
+0.40%-1.98%+3.52%+6.95% 31.15B
+0.79%-1.74%+6.95%+50.72% 28.97B
-2.33%-3.91%-8.20%+14.95% 25.76B
+1.00%+1.10%+45.27%+34.99% 23.12B
-1.16%-4.47%+47.37%+7.46% 18.32B
-0.53%-0.78%-44.94%-42.26% 17.45B
Average -0.61%-2.81%+1.80%+4.83% 29.25B
Weighted average by Cap. -0.22%-2.19%+5.07%+22.75%

Financials

2024 2025
Net sales 8.57M 853K 758K 708K 646K 1.22M 82.11M 1.23M 3.32M 41.82M 3.2M 3.13M 134M 18.45M 1.84M 1.63M 1.52M 1.39M 2.62M 177M 2.65M 7.14M 90.01M 6.89M 6.74M 289M
Net income -17.81M -1.77M -1.57M -1.47M -1.34M -2.53M -171M -2.56M -6.9M -86.92M -6.66M -6.51M -279M -17.63M -1.75M -1.56M -1.46M -1.33M -2.5M -169M -2.53M -6.83M -86.04M -6.59M -6.45M -276M
Net Debt -14.36M -1.43M -1.27M -1.19M -1.08M -2.04M -138M -2.06M -5.56M -70.07M -5.37M -5.25M -225M 1.64M 164K 145K 136K 124K 233K 15.75M 236K 636K 8.02M 614K 601K 25.77M
Logo aXichem AB
aXichem AB (publ) is a Sweden-based biochemical company. It develops an eco-friendly solution, Phenylcapsaicin. Phenylcapsaicin is an non-toxic antifouling agent, which can be used in the shipping industry, as it keeps vessels free from fouling. Additionally, the Company holds several world patents for alternative uses and applications of phenylcapsaicin. Phenylcapsaicin can be applied as bio-repellent against all living organisms in settings where animals cause damage to human installations. As of December 31, 2011, the Company had such subsidiaries, as aXichem AB, aXimed AS, aXimed KH Limited and Guizhou aXimed Health Food Co Ltd. As of June 29, 2012, the Compant’s two largest shareholders were Aximed AB (52.47%) and LMK Ventures AB (12.54%).
Employees
7
Date Price Change Volume
26-10-02 SEK 1.905 -4.75% 58,004
26-10-01 SEK 2.000 -6.98% 139,849
26-09-30 SEK 2.150 +0.47% 25,039
26-09-29 SEK 2.140 -1.83% 52,074
26-09-28 SEK 2.180 +3.81% 3,470
  1. Stock Market
  2. Stocks
  3. AXIC A Stock